Incyte Falls After Patient Develops Infection

Incyte Corp., the maker of the drug Jakafi for bone marrow disease, fell the most in three months after a patient on the drug developed a viral infection.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.